The augmented biosynthesis of cholesterol observed in tumors is consistent with the resistance of tumor HMGCR and SREBP-2 (Chen and Hughes-Fulford, 2001) to the cholesterol-mediated feedback inhibition that was initially observed in mouse hepatoma BW-7756 (Siperstein and Fagan, 1964). Here, SREBF2 is linked to neoplasm.